Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Home

Main sub menu

  • Investors
  • Careers
    • Working at Recipharm
    • The Recipharm story
    • Meet our employees
    • Current vacancies
  • Contact
    • Contact us
    • Development services contacts
    • Manufacturing services contacts
    • Locations
      • France
        • Fontaine
        • Kaysersberg
        • Monts
        • Pessac
      • Germany
        • Monheim
        • Wasserburg
        • Zwickau
      • India
        • Bengaluru
        • Karnal / Paonta Sahib
      • Israel
        • Ness Ziona
      • Italy
        • Brescia
        • Lainate
        • Masate
        • Paderno Dugnano
        • Pianezza
      • Portugal
        • Odivelas
        • Queluz
      • Spain
        • Parets
        • Leganés
      • Sweden
        • Höganäs
        • Stockholm city (HQ)
        • Karlskoga
        • Solna
        • Stockholm
        • Strängnäs
        • Uppsala
        • Uppsala Development
      • UK
        • Ashton
        • Cramlington
        • Holmes Chapel
        • Queenborough
      • USA
        • Research Triangle Park

Main navigation

  • Development
    • Drug substance
    • Drug product
    • Analytical chemistry
    • Clinical trial material (CTM)
  • Manufacturing
    • Solids
    • Semi-solids
    • Liquids
    • Inhalation
    • Injectables
    • Ophthalmics
  • Solutions
    • Recipharm Analytical Solutions™
    • Recipharm Inhalation Solutions™
    • Recipharm Pathway to Clinic®
    • Serialisation
  • Bespak
  • Learn
  • Press & events
    • Press
    • Events
    • Reports
    • Insights
  • Our story
    • Recipharm in brief
    • Business model
    • Business overview
    • Sustainability
    • Company history

Press & events

What's happening?

Stay updated on our latest news and events.

Press and Event

  • Press
  • Events
  • Reports
  • Insights
Displaying 181 - 190 of 356

Subscribe

Press

Recipharm in discussions with Alcon regarding long-term manufacturing agreement

2015.09.07 Read more

Press

Recipharm Signs Agreement with RedHill Biopharma for Manufacturing of RHB-105 for treatment of H. pylori infection

2015.08.26 Read more

Press

Change in the total number of shares and votes in Recipharm AB (publ)

2015.07.31 Read more

Press

Interim report January-June 2015

2015.07.23 Read more

Press

Invitation to presentation of Recipharm’s interim report for the first quarter on 23 July 2015

2015.07.20 Read more

Press

Recipharm secures additional bank financing for continued growth

2015.07.13 Read more

Press

Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest’s lead drug candidate SHACT

2015.07.09 Read more

Press

Recipharm Reduces Risk and Improves Compliance with Infor

2015.07.07 Read more

Press

Change in the total number of shares and votes in Recipharm AB (publ)

2015.06.30 Read more

Press

Recipharm appoints new Sales Director, Development Services

2015.06.29 Read more

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Current page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • …
  • Next page Next ›
  • Last page Last »

Footer menu

  • Privacy policy
  • Cookies
  • Website terms
  • T&C of sale and delivery
© 2020 Recipharm AB (publ). All rights reserved Stormfors Digitalbyrå